MRL VENTURES FUND LLC purchased 1.4% of their position (25K shares) of TRANSLATE BIO, INC. on the open market
Open‑market purchase worth $325.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/3/2018ACC: 0000899243-18-019325
10% Owner
Since Jul 2018
-8.40M
Net shares
Net seller
$325.0K
Total acquired
1
Open market trades
1B · 0S
4
Total transactions
1.87M acquired · 10.27M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.85M
Price / share
—
Trade value
—
% of position
New position
7/2/2018
0.00→1.85M
Common Stock
Direct
Shares
+25K
Price / share
$13.00
Trade value
$325K
% of position
1.4%
7/2/2018
1.85M→1.87M
Total
Net shares
+1.87M
Net value
$325K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/2/2018 | C · Conversion | +1.85M | — | — | New position | 0.00 | 1.85M |
| Common Stock Direct | 7/2/2018 | P · Purchase | +25K | $13.00 | $325K | 1.4% | 1.85M | 1.87M |
| Total | +1.87M | $325K | ||||||
Derivative Transactions2
Series B Preferred Stock
Direct
Converts to
Common Stock
1.67M shares
Shares
−9.26M
Strike price
Held after
0.00
Exercisable
—
7/2/2018
Series C Preferred Stock
Direct
Converts to
Common Stock
181.82K shares
Shares
−1.01M
Strike price
Held after
0.00
Exercisable
—
7/2/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Direct | Common Stock1.67M shares | 7/2/2018 | C · Conversion | −9.26M | — | 0.00 | |
| Series C Preferred Stock Direct | Common Stock181.82K shares | 7/2/2018 | C · Conversion | −1.01M | — | 0.00 |